The Ministry of Food and Drug Safety said that innotox produced by Medytox should be temporarily suspended from manufacturing, sales, and use of the item and initiated administrative disposition procedures such as cancellation of product permission.The Ministry of Food and Drug Safety (hereinafter referred to as the Ministry of Food and Drug Safety) said that on December 22, the Innotox wine produced by Medytox should be temporarily suspended from manufacturing, sales, and use of the product and initiated administrative disposition procedures such as cancellation of product permission.
This disposition is based on the results of investigation by the prosecutors on the suspicion of manipulation of documents submitted by Innotox, which was reported to the National Rights Commission as a public interest report. He confirmed the violation of counterfeiting and charged him for obstructing the execution of public affairs by hierarchies under Article 137 of the Penal Code.
The Ministry of Food and Drug Safety has confirmed the relevant items and violations by receiving notification of the licensed crime from the prosecution, and as a result, if the company has obtained product permission and change permission by fraudulent or other fraudulent methods (Pharmaceutical Affairs Act Article 76 (1) 2-3) ), the item permission cancellation procedure was initiated.
The Ministry of Food and Drug Safety temporarily ordered the suspension of manufacturing and sales to protect consumers and prevent harm in advance, taking into consideration that the administrative procedure for revocation of the license takes time, while distributing safety bulletins to medical personnel, the Health Insurance Review and Assessment Service, and related organizations immediately. Requested to stop using it.
The Ministry of Food and Drug Safety is planning to expedite the administrative procedure for the drug manufacturer, and requested medical personnel and related organizations to actively cooperate with the administrative procedure in the future.